Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
Apr. 30, 2025	Apr. 30, 2024
Income Statement [Abstract]
Net sales	$ 240,472	$ 203,755
Cost of products sold	171,615	151,704
Gross profit	68,857	52,051
Operating expenses	51,098	33,770
Operating earnings	17,759	18,281
Pension expense	0	(4,177)
Other income, net	240	814
Interest expense	(3,214)	(1,799)
Earnings before income taxes	14,785	13,119
Income tax expense (benefit)	3,202	(5,938)
Net earnings	11,583	19,057
Less: net earnings attributable to the non-controlling interest	178	304
Net earnings attributable to Kewaunee Scientific Corporation	$ 11,405	$ 18,753
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders
Basic (in usd per share)	$ 3.98	$ 6.51
Diluted (in usd per share)	$ 3.83	$ 6.38
Weighted average number of common shares outstanding
Basic (in shares)	2,862	2,879
Diluted (in shares)	2,979	2,938

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(2)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(2)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1